About one in three Americans have at least three risk factors for cardiovascular-kidney-metabolic (CKM) syndrome, yet there are no clinical practice guidelines for its treatment. Prevention, screening, management, and treatment of these diseases lacks uniformity.
To address needs around CKM syndrome, the American Heart Association (AHA) launched the Cardiovascular-Kidney-Metabolic Health Initiative, a 4-year plan to implement a person-centered approach to awareness, professional and patient education, and treatment of CKM syndrome.
Supported by Novo Nordisk and Boehringer Ingelheim, the initiative will evaluate gaps in clinical care, identify areas for future research, and implement guidelines and screening recommendations to provide definitive advice for treatment. As part of the effort, the AHA will work with the American College of Physicians, American Diabetes Association, American Society of Nephrology, National Kidney Foundation, and STOP Obesity Alliance at the Milken Institute School of Public Health in Washington, DC. The initiative will engage 150 hospitals and other sites across the nation and reach more than 265,000 patients.
In addition, the AHA will expand CKM health measures in its existing hospital-based quality improvement initiative, Get With the Guidelines, and outpatient data registries. It will also develop a CKM recognition program for health care professionals and health systems dedicated to improving CKM care and develop a scalable patient-centered certification framework in collaboration with the Cardiometabolic Center Alliance to improve treatment for CKM syndrome.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.